Conference item : Abstract
Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 79.8KB, Terms of use)
-
- Publisher copy:
- 10.1093/rheumatology/keab247.167
Authors
- Publisher:
- Oxford University Press
- Journal:
- Rheumatology More from this journal
- Volume:
- 60
- Issue:
- S1
- Pages:
- 90-91
- Publication date:
- 2021-04-26
- Acceptance date:
- 2020-12-11
- Event title:
- British Society for Rheumatology Annual Conference 2021
- Event location:
- SEC Glasgow and online
- Event website:
- https://www.rheumatology.org.uk/events-learning/conferences/annual-conference
- Event start date:
- 2021-04-25
- Event end date:
- 2021-04-27
- DOI:
- EISSN:
-
1462-0332
- ISSN:
-
1462-0324
- Language:
-
English
- Keywords:
- Subtype:
-
Abstract
- Pubs id:
-
1187873
- Local pid:
-
pubs:1187873
- Deposit date:
-
2021-08-06
- ARK identifier:
Terms of use
- Copyright holder:
- Coates et al.
- Copyright date:
- 2021
- Rights statement:
- © The Authors 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record